MedPath

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

Not Applicable
Completed
Conditions
Portal Hypertension
Ascites Hepatic
Cirrhosis, Liver
Registration Number
NCT05928624
Lead Sponsor
University of California, San Francisco
Brief Summary

This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.

Detailed Description

This is a feasibility trial to determine the feasibility of using home monitoring devices (e.g. blood pressure cuffs) to improve outcomes for cirrhosis patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Patients will need to have decompensated cirrhosis defined as a Child Pugh Score ≥ 7
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Mean Arterial PressureBaseline and 24 Weeks

The investigators will compare the change in mean arterial pressure before and after utilization of the data generated from the home monitoring.

Secondary Outcome Measures
NameTimeMethod
Change in Ascites BurdenBaseline and 24 Weeks

The investigators will compare the change in ascites burden, defined as the total volume of ascites removed during the study period, before and after utilization of the data generated from the home monitoring.

Trial Locations

Locations (1)

University of California San Francisco

🇺🇸

San Francisco, California, United States

University of California San Francisco
🇺🇸San Francisco, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.